Grant: Foundation Grant

High-performance platforms that diagnose disease and predict the progression of disease are urgently needed for both clinical patient care and clinical research. The aim of my research group is to generate novel systems applicable to the detection and characterization of cancer, infectious disease and other disease states. In order to accomplish this goal, we have developed platforms that integrate molecular analysis into disease diagnostics with superior sensitivity and specificity to technology that is currently available. We are developing a toolbox of assays that report on specific disease markers and we will use these developed technologies to further understand the role cellular biomarkers play in disease progression. These assays will be translated for clinical use to enable precision medicine based on molecular-level information to become routine. This research has the potential to impact current detection and treatment considerations for cancer and infectious disease in health care settings.